Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Lotus Pharmaceutical

Market Cap: NT$61.9b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Oneness Biotech

Market Cap: NT$27.7b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

TaiMed Biologics

Market Cap: NT$22.1b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

EirGenix

Market Cap: NT$19.2b

Operates as a contract development and manufacturing company in Taiwan and internationally.

Medigen Vaccine Biologics

Market Cap: NT$16.2b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

Handa Pharmaceuticals

Market Cap: NT$13.2b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

Foresee Pharmaceuticals

Market Cap: NT$10.0b

Operates as biopharmaceutical company in the United States, China, and Europe.

Formosa Laboratories

Market Cap: NT$8.6b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

TCM Biotech International

Market Cap: NT$3.4b

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.